D L Joseph Davey1, H I Shull, J D Billings, D Wang, K Adachi, J D Klausner. 1. From the *David Geffen School of Medicine at UCLA, †Fielding School of Public Health, Department of Epidemiology, and ‡Fielding School of Public Health, Department of Biostatistics, UCLA, Los Angeles, CA.
Abstract
BACKGROUND: Current literature comparing the prevalence rates of curable sexually transmitted infections (STIs) in pregnant women in various global regions is limited. As a result, antenatal screening practices for curable STIs in pregnant women, specifically Treponema pallidum (syphilis), Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV) vary around the world, differing by country and particular STI. METHODS: We conducted a systematic review of publications on STI prevalence among pregnant women in 30 different low- and middle-income countries. We searched PubMed for studies reporting prevalence of syphilis, CT, NG, and TV in pregnant women. English language studies published between January 1, 2010, and March 1, 2015, were included. The adjusted mean STI prevalence by region was calculated via multivariable linear regression adjusting for health care setting, women's mean age, study sample size, and sensitivity of diagnostic test. RESULTS: We identified 75 studies that met inclusion criteria, providing 116 point prevalence estimates for curable STIs among 3,489,621 pregnant women. Adjusted mean prevalence for NG ranged from 1.2% (95% confidence interval [CI], 1.0-1.3) in Latin America to 4.6% (95% CI, 4.0-5.2) in Southern Africa; syphilis prevalence ranged from 1.1% (95% CI, 0.5-1.6) in Asia to 6.5% (95% CI, 4.7-6.3) in Southern Africa; CT ranged from 0.8% (95% CI, 0.4-1.1) in Asia to 11.2% (95% CI, 6.0-16.4) in Latin America; and TV ranged from 3.9% (95% CI, 2.2-5.6) in Latin America to 24.6% (95% CI, 17.9-31.4) in Southern Africa. CONCLUSIONS: Although we observed a wide variation in STI burden in pregnancy after adjusting for age, test, and health care setting, further valid comparison may depend on adjustment for access to care and screening practices.
BACKGROUND: Current literature comparing the prevalence rates of curable sexually transmitted infections (STIs) in pregnant women in various global regions is limited. As a result, antenatal screening practices for curable STIs in pregnant women, specifically Treponema pallidum (syphilis), Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV) vary around the world, differing by country and particular STI. METHODS: We conducted a systematic review of publications on STI prevalence among pregnant women in 30 different low- and middle-income countries. We searched PubMed for studies reporting prevalence of syphilis, CT, NG, and TV in pregnant women. English language studies published between January 1, 2010, and March 1, 2015, were included. The adjusted mean STI prevalence by region was calculated via multivariable linear regression adjusting for health care setting, women's mean age, study sample size, and sensitivity of diagnostic test. RESULTS: We identified 75 studies that met inclusion criteria, providing 116 point prevalence estimates for curable STIs among 3,489,621 pregnant women. Adjusted mean prevalence for NG ranged from 1.2% (95% confidence interval [CI], 1.0-1.3) in Latin America to 4.6% (95% CI, 4.0-5.2) in Southern Africa; syphilis prevalence ranged from 1.1% (95% CI, 0.5-1.6) in Asia to 6.5% (95% CI, 4.7-6.3) in Southern Africa; CT ranged from 0.8% (95% CI, 0.4-1.1) in Asia to 11.2% (95% CI, 6.0-16.4) in Latin America; and TV ranged from 3.9% (95% CI, 2.2-5.6) in Latin America to 24.6% (95% CI, 17.9-31.4) in Southern Africa. CONCLUSIONS: Although we observed a wide variation in STI burden in pregnancy after adjusting for age, test, and health care setting, further valid comparison may depend on adjustment for access to care and screening practices.
Authors: Blanca Samayoa; Matthew Robert Anderson; Karla Patricia Alonso Pacheco; Carol Lee; Alicia Pittard; Alex Soltren; Ingrid Barrios Matos; Eduardo Arathoon Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2010-09-14
Authors: Robert L Cook; Shari L Hutchison; Lars Østergaard; R Scott Braithwaite; Roberta B Ness Journal: Ann Intern Med Date: 2005-06-07 Impact factor: 25.391
Authors: Li Liu; Hope L Johnson; Simon Cousens; Jamie Perin; Susana Scott; Joy E Lawn; Igor Rudan; Harry Campbell; Richard Cibulskis; Mengying Li; Colin Mathers; Robert E Black Journal: Lancet Date: 2012-05-11 Impact factor: 79.321
Authors: Mira Johri; Rosa E Morales; Jean-François Boivin; Blanca E Samayoa; Jeffrey S Hoch; Carlos F Grazioso; Ingrid J Barrios Matta; Cécile Sommen; Eva L Baide Diaz; Hector R Fong; Eduardo G Arathoon Journal: BMC Pregnancy Childbirth Date: 2011-07-06 Impact factor: 3.007
Authors: John D T Lawi; Mariam M Mirambo; Moke Magoma; Martha F Mushi; Hyasinta M Jaka; Balthazary Gumodoka; Stephen E Mshana Journal: BMC Pregnancy Childbirth Date: 2015-01-22 Impact factor: 3.007
Authors: Maanda Mudau; Remco P Peters; Lindsey De Vos; Dawie H Olivier; Dvora J Davey; Edwin S Mkwanazi; James A McIntyre; Jeffrey D Klausner; Andrew Medina-Marino Journal: Int J STD AIDS Date: 2017-08-11 Impact factor: 1.359
Authors: Jeremiah Laktabai; Victoria L Mobley; Wendy Prudhomme-O'Meara; Steve M Taylor Journal: Am J Trop Med Hyg Date: 2022-07-05 Impact factor: 3.707
Authors: Weiming Tang; Jessica Mao; Katherine T Li; Jennifer S Walker; Roger Chou; Rong Fu; Weiying Chen; Toni Darville; Jeffrey Klausner; Joseph D Tucker Journal: Sex Transm Infect Date: 2019-12-13 Impact factor: 3.519
Authors: Eline L M Op de Coul; Demi Peek; Yolanda W M van Weert; Servaas A Morré; Ingrid Rours; Chantal Hukkelhoven; Ank de Jonge; Birgit van Benthem; Monique Pereboom Journal: Reprod Health Date: 2021-06-26 Impact factor: 3.223
Authors: Olga P M Saweri; Neha Batura; Rabiah Al Adawiyah; Louise M Causer; William S Pomat; Andrew J Vallely; Virginia Wiseman Journal: PLoS One Date: 2021-06-17 Impact factor: 3.240